Clinical Trials Directory

Trials / Sponsors / Amgen Research (Munich) GmbH

Amgen Research (Munich) GmbH

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedClinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Diffuse Large B-cell Lymphoma
Phase 22012-07-01
CompletedClinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acu
Acute Lymphoblastic Leukemia
Phase 1 / Phase 22012-01-01
CompletedClinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
Phase 22011-12-01
CompletedConfirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor A
B-cell Acute Lymphoblastic Leukemia
Phase 22010-11-01
CompletedStudy of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphobla
B-ALL
Phase 22010-10-01
CompletedStudy of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases
Liver Metastases, Colorectal Cancer
Phase 22009-03-01
CompletedA Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)
Healthy Volunteers
Phase 12008-05-01
CompletedPhase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the
Solid Tumors
Phase 12008-03-01
CompletedPhase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acut
Acute Lymphoblastic Leukemia
Phase 22008-01-01
CompletedSafety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL
Non-Hodgkin's Lymphoma, Relapsed
Phase 12004-06-01